Company intelligence / Profile preview

NVT Group

Ownership: Private
Development stage: Other

Overview

NVT develops minimally invasive medical devices for the treatment of valvular heart disease. Their products are used in interventional cardiology and cardiac surgery to improve patient outcomes by making procedures safer and easier. The company collaborates closely with physicians and medical facilities to ensure safety and efficacy in their offerings.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Biosensors International Group

Beyond the preview

Go deeper on NVT Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NVT Group.

Explore the full profile